Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. [electronic resource]
Producer: 20051214Description: 2402-11 p. digitalISSN:- 0021-9738
- Animals
- Apoptosis -- physiology
- Bone Density
- Bone Diseases, Metabolic -- genetics
- Bone and Bones -- anatomy & histology
- Gene Targeting
- Male
- Mice
- Mice, Knockout
- Mice, Transgenic
- Osteoblasts -- cytology
- Osteogenesis -- physiology
- Osteoporosis -- pathology
- Parathyroid Hormone -- administration & dosage
- Parathyroid Hormone-Related Protein -- genetics
- Peptide Fragments -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.